Audentes Therapeutics (BOLD) Tops Q4 EPS by 9c

March 8, 2018 4:04 PM

Audentes Therapeutics (NASDAQ: BOLD) reported Q4 EPS of ($0.82), $0.09 better than the analyst estimate of ($0.91).

For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.

Categories

Earnings Guidance